Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol Anti-biofilm Effects
NCT03678012Phase 1Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ferumoxytol in dental caries (3 arms), sponsored by University of Pennsylvania. Primary endpoints: Biofilm Analyses-cell viability at 14 days and Biofilm Analysis-extracellular polysaccharides at 14 days. Started Jun 2018; status: completed.
02
Drugs
ferumoxytol
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03678012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03678012.